Cancer Communications
indexed by SCI
BMC

Important notice

 

 

We would like to inform you that Chinese Journal of Cancer has changed the title to Cancer Communications on 1st March 2018.
Cancer Communications is published by Wiley from 1 January 2020. The journal website is available at: https://onlinelibrary.wiley.com/journal/25233548

 

 

Cancer Communications 2020年影响因子突破10分

Cancer Communications (CJC) 获评“2019中国最具国际影响力学术期刊”


Prognostic value of single-nucleotide polymorphisms for extranodal natural killer/T-cell lymphoma: the identification of risk factors in the molecular era
Sang Eun Yoon,Won Seog Kim
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 9/14/2021   doi:10.1002/cac2.12212
Novel strategy for disease risk prediction incorporating predicted gene expression and DNA methylation data: a multi-phased study of prostate cancer
Chong Wu,Jingjing Zhu,Austin King,Xiaoran Tong,Qing Lu,Jong Y. Park,Liang Wang,Guimin Gao,Hong-Wen Deng,Yaohua Yang,Karen E. Knudsen,Timothy R. Rebbeck,Jirong Long,Wei Zheng,Wei Pan,David V. Conti,Christopher A Haiman,Lang Wu
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 9/14/2021   doi:10.1002/cac2.12205
Transcription factor TFE3 enhances cell cycle and cancer progression by binding to the hTERT promoter
Beiping Miao,Chaoyang Zhang,Nadine Stroh,Lukas Brenner,Katrin Hufnagel,J?rg D. Hoheisel,Obul Reddy Bandapalli
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 9/14/2021   doi:10.1002/cac2.12216
A novel intronic circular RNA, circGNG7, inhibits head and neck squamous cell carcinoma progression by blocking the phosphorylation of heat shock protein 27 at Ser78 and Ser82
Houyu Ju,Zhenrong Hu,Dongliang Wei,Jinyun Huang,Xinyi Zhang,Mengyu Rui,Zhi Li,Xiaomeng Zhang,Jingzhou Hu,Wei Guo,Guoxin Ren
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 9/9/2021   doi:10.1002/cac2.12213
A moonlighting function of choline kinase alpha 2 in the initiation of lipid droplet lipolysis in cancer cells
Qingxia Ma,Zhaoyuan Meng,Ying Meng,Rui Liu,Zhimin Lu
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 8/27/2021   doi:10.1002/cac2.12211
Genetic alternations and immune characteristics in patients with small cell lung cancer
Chenyue Zhang,Chenglong Zhao,Haiyong Wang
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 8/24/2021   doi:10.1002/cac2.12208
Non-recovery of renal function was correlated with increased mortality in the cancer cohort with septic shock
June-sung Kim,Youn-Jung Kim,Won Young Kim
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 8/21/2021   doi:10.1002/cac2.12209
Global patterns of breast cancer incidence and mortality: A population-based cancer registry data analysis from 2000 to 2020
Shaoyuan Lei, Rongshou Zheng, Siwei Zhang, Shaoming Wang, Ru Chen, Kexin Sun, Hongmei Zeng, Jiachen Zhou, Wenqiang Wei
[ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 8/16/2021   doi:10.1002/cac2.12207
Clinical outcomes of second-line treatment following first-line VEGFR-TKI failure in patients with metastatic renal cell carcinoma: a comparison of axitinib alone and axitinib plus anti-PD-1 antibody
Jiwei Huang, Yueming Wang, Haoran Zhang, Xiaoyi Hu, Ping Wang, Wen Cai, Yichu Yuan, Hao Zeng, Jin Zhang, Wen Kong, Yiran Huang, Shuo Wang, Jianming Guo, Qiang Wei, Wei Xue
[ [ Abstract  0]    [ PDF Full-text  0]    [ PubMed]   Epub: 8/7/2021   doi:10.1002/cac2.12206
Harness the functions of gut microbiome in tumorigenesis for cancer treatment
Mong-Hong Lee
[ [ Abstract  0]    [ PDF Full-text  0]    [ PubMed]   Epub: 8/6/2021   doi:10.1002/cac2.12200

more papers...






Gastric cancer  

 

Edited by Yun Dai and Li Yan
 

This thematic series discusses the molecular classifications of gastric cancer by the Cancer Genome Atlas (TCGA) and the Asian Cancer Research Group (ACRG) as well as the implications in personalized therapeutic choices; discusses the evolution of gastric surgery and presents perspectives on surgical techniques in treating gastric cancer; and reviews current and emerging targeted agents as well as immunotherapies in treating gastric cancer. With these advancements in molecular characterization, surgical intervention, and targeted and immunotherapies, gastric cancer will enter a personalized medicine era in the next 5 years.

 

Read thematic series > 

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 

Tumor angiogenesis  

 

Edited by Francesco Pezzella
and Chao-Nan Qian 

Forming efficient vasculature network, also known as tumor angiogenesis, is a critical hallmark in tumor development. Explorations on its underlying molecular mechanisms have resulted in several novel anti-cancer drugs. However, the modest survival benefits from anti-angiogenic therapy have forced us to revisit our understanding on tumor angiogenesis. In this special issue, world-leading experts have contributed their critical thoughts to reveal alternative tumor angiogenesis approaches and potential treatment targets.

 

Read thematic series > 

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 

Lung cancer 


 

Edited by Lin Yan and Wei Zhang  

 

Lung cancer accounts for approximately 21% of worldwide cancer deaths and a staggering 1.6 million new cases are diagnosed every year. In China, lung cancer has become a particularly challenging disease because of air pollution and smoking. This thematic series discusses the proper use of targeted agents in treating lung cancer, reviews the application of biomarkers in clinical management and drug development, and analyzes the unique challenges in developing novel drugs for lung cancer in China.

 

Read thematic series > 



CJC Wechat 微信公众号


 

Editorial Manager


CC adopts ScholarOne Manuscripts to manage its submissions from Nov.1, 2019

 Submission Guidelines  

 

Reference style for  

 EndNote,
 Reference Manager



Editorial Manager


 

Year:

 

Month:

Advanced search

Subscription


CC is now published by Wiley

© Cancer Communications

651 Dongfeng Road East,Guangzhou 510060, P.R.China